Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Radiotherapy and concurrent chemotherapy: a strategy that improves locoregional control and survival in oropharyngeal cancer.

× No keyword cloud information.

14 in total

1. Treatment selection in oropharyngeal cancer: a surveillance, epidemiology, and end results (SEER) patterns of care analysis.

Authors: Nitin A Pagedar; Catherine Chioreso; Jennifer A Schlichting; Charles F Lynch; Mary E Charlton
Journal: Cancer Causes Control Date: 2017-08-16 Impact factor: 2.506

2. Neoadjuvant chemotherapy: does it have benefits for the surgeon in the treatment of advanced squamous cell cancer of the oral cavity?

Authors: Lajos Olasz; József Szalma; Eniko Orsi; Tamás Tornóczky; Tamás Markó; Zoltán Nyárády
Journal: Pathol Oncol Res Date: 2009-09-12 Impact factor: 3.201

3. Swallowing dysfunction is a common sequelae after chemoradiation for oropharynx carcinoma.

Authors: Kathryn M Greven; Douglas R White; J Dale Browne; Daniel W Williams; W Fred McGuirt; Ralph B D'Agostino
Journal: Am J Clin Oncol Date: 2008-06 Impact factor: 2.339

Review 4. Oral cancer treatment.

Authors: Terry A Day; Betsy K Davis; M Boyd Gillespie; John K Joe; Megan Kibbey; Bonnie Martin-Harris; Brad Neville; Mary S Richardson; Steven Rosenzweig; Anand K Sharma; Michelle M Smith; Stacy Stewart; Robert K Stuart
Journal: Curr Treat Options Oncol Date: 2003-02

5. Concurrent radiochemotherapy in locally-regionally advanced oropharyngeal squamous cell carcinoma: analysis of treatment results and prognostic factors.

Authors: Valentina Krstevska; Igor Stojkovski; Beti Zafirova-Ivanovska
Journal: Radiat Oncol Date: 2012-05-28 Impact factor: 3.481

Review 6. Immune suppression in head and neck cancers: a review.

Authors: Anaëlle Duray; Stéphanie Demoulin; Pascale Hubert; Philippe Delvenne; Sven Saussez
Journal: Clin Dev Immunol Date: 2011-03-10

7. Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies.

Authors: J P Hong; S-W Lee; S Y Song; S D Ahn; S S Shin; E K Choi; J H Kim
Journal: Eur J Cancer Care (Engl) Date: 2009-04-23 Impact factor: 2.520

Review 8. Oropharyngeal cancer: the role of chemotherapy.

Authors: David J Adelstein
Journal: Curr Treat Options Oncol Date: 2003-02

9. Towards neuroimmunotherapy for cancer: the neurotransmitters glutamate, dopamine and GnRH-II augment substantially the ability of T cells of few head and neck cancer patients to perform spontaneous migration, chemotactic migration and migration towards the autologous tumor, and also elevate markedly the expression of CD3zeta and CD3epsilon TCR-associated chains.

Authors: Sven Saussez; Barbara Laumbacher; Gilbert Chantrain; Alexandra Rodriguez; Songhai Gu; Rudolf Wank; Mia Levite
Journal: J Neural Transm (Vienna) Date: 2014-07-17 Impact factor: 3.850

10. Transoral robotic surgery (TORS) for tongue base tumours.

Authors: G Mercante; P Ruscito; R Pellini; G Cristalli; G Spriano
Journal: Acta Otorhinolaryngol Ital Date: 2013-08 Impact factor: 2.124